DEA bids to exclude expert witnesses from psychedelics-ban hearing
The DEA wants to place DOI and DOC, which are currently unscheduled, in Schedule I of the Controlled Substances Act – the most restricted category, for drugs deemed to have “High abuse potential with no accepted medical use.” The agency revived these attempts in December 2023.
…the DEA’s filing includes a particularly lengthy section dedicated to discrediting the proposed testimony of David Heldreth… “DEA is attempting to restrict the testimony of the only group representing Native American viewpoints,” said Heldreth. Despite Heldreth’s work, the agency claims “there is no indication that he possesses any expertise to aid the tribunal in resolving the issue.” “We have assembled a world-class international group of behavioral and molecular pharmacologists, chemists, neuroscientists, and a former Government Advisor on psychoactive drugs,” added Student for Sensible Drug Policy’s Elijah Ullman, who is himself pursuing a PhD in molecular and systems pharmacology. “If the DEA believes that both DOI and DOC should be placed in Schedule I, they should have no issue allowing our witnesses to testify in full.”
Original Article (Filtermag)
DEA bids to exclude expert witnesses from psychedelics-ban hearing
Artwork Fair Use: Maksim Sokolov
Recent Comments